Protalix BioTherapeutics PLX
NYSE PLX
$2.57 +0.00 (+0.04%)
As of: Oct 22, 2026 · 10:18 AM EDT

Protalix BioTherapeutics (PLX) Liabilities from Discontinued Operations (2014 - 2016)

Updated

Protalix BioTherapeutics' Liabilities from Discontinued Operations was $293,000 in Q2 2016, up 128.9% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Liabilities from Discontinued Operations (2014 - 2016) Analysis & Trends

At the end of FY2015, Liabilities from Discontinued Operations at Protalix BioTherapeutics came in at $1.57 million, down 97.0% from FY2014.

  • In earlier years, Liabilities from Discontinued Operations was $52.83 million in FY2014.
  • Quarterly Liabilities from Discontinued Operations has moved between $128,000 (Q1 2016) and $52.83 million (Q4 2014) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn
10 Protalix BioTherapeutics 205.65 Mn 54.27 Mn 12.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 293,000.00
Mar 31, 2016 128,000.00
Dec 31, 2015 1.57 Mn
Dec 31, 2014 52.83 Mn
API Access

Protalix BioTherapeutics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=PLX&period=max&api_key=YOUR_API_KEY